FAQs About Crysvita for XLH
FAQs
Crysvita (burosumab) is a treatment for people with X-linked hypophosphatemia (XLH) developed by Kyowa Kirin and Ultragenyx. It is the only U.S. Food and Drug Administration-approved treatment for XLH that ... Read more